FCM
PTCT icon

Frontier Capital Management’s PTC Therapeutics PTCT Stock Holding History

Frontier Capital Management’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-103,229
Closed -$6.3M – 295
2020
Q4 		$6.3M Sell
103,229
-26,319
-20% -$1.55M 0.05% 251
2020
Q3 		$6.06M Sell
129,548
-76,261
-37% -$3.75M 0.05% 249
2020
Q2 		$10.4M Buy
205,809
+184,265
+855% +$9.05M 0.09% 217
2020
Q1 		$961K Sell
21,544
-57,731
-73% -$2.91M 0.01% 268
2019
Q4 		$3.81M Buy
79,275
+35,481
+81% +$1.51M 0.03% 258
2019
Q3 		$1.48M Sell
43,794
-96,794
-69% -$4.21M 0.01% 275
2019
Q2 		$6.33M Sell
140,588
-229,595
-62% -$9.07M 0.05% 251
2019
Q1 		$13.9M Buy
370,183
+191,004
+107% +$6.41M 0.1% 214
2018
Q4 		$6.15M Sell
179,179
-324,838
-64% -$11.7M 0.05% 257
2018
Q3 		$23.7M Buy
504,017
+447,735
+796% +$18.5M 0.15% 182
2018
Q2 		$1.9M Sell
56,282
-583,999
-91% -$18.2M 0.01% 287
2018
Q1 		$17.3M Buy
640,281
+535,076
+509% +$13.6M 0.13% 203
2017
Q4 		$1.75M Sell
105,205
-142,044
-57% -$2.4M 0.01% 278
2017
Q3 		$4.95M Sell
247,249
-1,064,509
-81% -$20.8M 0.04% 264
2017
Q2 		$24M Sell
1,311,758
-19,682
-1% -$265K 0.18% 172
2017
Q1 		$13.1M Sell
1,331,440
-38,297
-3% -$464K 0.1% 223
2016
Q4 		$14.9M Buy
1,369,737
+196,359
+17% +$2.06M 0.11% 212
2016
Q3 		$16.4M Sell
1,173,378
-260,597
-18% -$2.12M 0.13% 206
2016
Q2 		$10.1M Buy
1,433,975
+466,608
+48% +$3.42M 0.08% 237
2016
Q1 		$6.23M Buy
967,367
+715,383
+284% +$12.4M 0.05% 261
2015
Q4 		$8.16M Sell
251,984
-183,060
-42% -$5.39M 0.07% 262
2015
Q3 		$11.6M Sell
435,044
-183,681
-30% -$7.86M 0.1% 241
2015
Q2 		$29.8M Buy
+618,725
New +$36.1M 0.21% 164

Other funds holding PTCT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Frontier Capital Management's PTCT Position: Q1 2021 in Review

Frontier Capital Management sold out of PTC Therapeutics (PTCT) in Q1 2021, closing a stake of 103,229 shares — an estimated $6.3M sold.

Frontier Capital Management first reported a position in PTCT in Q2 2015 and held it in 23 quarters. The position peaked at $29.8M in Q2 2015. 208 funds tracked by Wall St. Rank hold PTCT as of Q1 2021.

  • Frontier Capital Management reported no remaining PTC Therapeutics position as of Q1 2021 after selling out during the quarter.
  • Frontier Capital Management sold 103,229 PTC Therapeutics shares in Q1 2021, an estimated $6.3M.
  • Frontier Capital Management first reported a position in PTC Therapeutics in Q2 2015 and held it in 23 quarters.
  • Frontier Capital Management's PTC Therapeutics position peaked at $29.8M in Q2 2015.
  • 208 funds tracked by Wall St. Rank held PTC Therapeutics as of Q1 2021.

Based on Frontier Capital Management's 13F filing for Q1 2021, filed 13 May 2021.